<DOC>
	<DOCNO>NCT03023631</DOCNO>
	<brief_summary>The goal clinical research study learn Gardasil ( HPV vaccine ) prevent HPV infection HPV-related disease give blood cancer patient receive stem cell transplant .</brief_summary>
	<brief_title>HPV Antibody Response After GARDASIL 9 Vaccination Participants After Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description>If participant agrees take part study , 6-12 month stem cell transplant : - Participant receive Gardasil 3 injection 3 separate timepoints skin arm thigh . Participant receive vaccination 6 month ( +/- 8 week ) stem cell transplant , 2 month first injection , 4 month second injection . - Blood ( 1 tablespoon ) drawn test HPV antibody first vaccination , 1 month 6 month . HPV antibody create immune system may protect participant infection HPV-related disease future . Participant give dose diary record side effect vaccination . Follow-Up : Participant call within 3 day vaccination ask side effect . If doctor think need , participant visit clinic physical exam . Length Study : Participant receive 3 vaccination . Participant receive 3 vaccination disease get bad , intolerable side effect occur , unable follow study direction . Participation study participant 's last follow-up phone call ( within 3 day third vaccination ) . This investigational study . Gardasil FDA approve commercially available prevention HPV infection HPV-related disease . Studying effectiveness Gardasil patient receive stem cell transplant consider investigational . The study staff explain Gardasil design work . Up 48 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>1 . All Englishspeaking adult ( 18 year old ) MD Anderson patient hematologic malignancy 612 month +/ 8 week post allogeneic stem cell transplantation receive usual poststem cell transplant vaccination . 2 . All patient approve protocol 20150795 invited vaccine study . 1 . Prior allogeneic SCT 2 . Platelet count less equal 25,000 K/µL . 3 . Absolute neutrophil count less equal 500/µL . 4 . Patients ever receive HPV vaccination ( least one dose HPV vaccine ) . 5 . Patients prior history HPVrelated malignancy . 6 . Female patient test positive pregnancy preSCT evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GARDASIL 9</keyword>
	<keyword>Post allogeneic stem cell transplantation</keyword>
	<keyword>HPV infection prevention</keyword>
</DOC>